Abstract
The intracellular free calcium concentration subserves complex signaling roles in brain. Calcium cations (Ca2+) regulate neuronal plasticity underlying learning and memory and neuronal survival. Homo- and heterocellular control of Ca2+ homeostasis supports brain physiology maintaining neural integrity. Ca2+ fluxes across the plasma membrane and between intracellular organelles and compartments integrate diverse cellular functions. A vast array of checkpoints controls Ca2+, like G protein-coupled receptors, ion channels, Ca2+ binding proteins, transcriptional networks, and ion exchangers, in both the plasma membrane and the membranes of mitochondria and endoplasmic reticulum. Interactions between Ca2+ and reactive oxygen species signaling coordinate signaling, which can be either beneficial or detrimental. In neurodegenerative disorders, cellular Ca2+-regulating systems are compromised. Oxidative stress, perturbed energy metabolism, and alterations of disease-related proteins result in Ca2+-dependent synaptic dysfunction, impaired plasticity, and neuronal demise. We review Ca2+ control processes relevant for physiological and pathophysiological conditions in brain tissue. Dysregulation of Ca2+ is decisive for brain cell death and degeneration after ischemic stroke, long-term neurodegeneration in Alzheimer's disease, Parkinson's disease, Huntington's disease, inflammatory processes, such as in multiple sclerosis, epileptic sclerosis, and leucodystrophies. Understanding the underlying molecular processes is of critical importance for the development of novel therapeutic strategies to prevent neurodegeneration and confer neuroprotection. Antioxid. Redox Signal. 14, 1275–1288.
Introduction: General Principles of Calcium Cations Signaling
Cellular signaling requires harnessing protein functions by charge distribution in response to the changing environment (17). Besides phosphate anions, calcium cations (Ca2+) are predestined to alter protein conformation, since Ca2+ can accommodate 4–12 oxygen atoms in its primary coordination sphere. Under physiological conditions, electrical pulses or receptor-mediated stimuli in the neuron generate different Ca2+ signals with distinct spatial dimensions, temporal extension, amplitude, subcellular localization, and, in some cases, oscillations. Spatial variability ranges from nanodomains in cellular organelles up to gradients covering the whole cell body.
The versatility of Ca2+ as an intracellular messenger is derived from varying cytosolic Ca2+ concentrations, most of which are generated by regulated openings of Ca2+-permeable channels expressed in the plasma membrane and in different organelles.
High signal speed and effectiveness is achieved by a 20,000-fold gradient between the low intracellular free Ca2+ concentration ([Ca2+]i) and high extracellular Ca2+ concentration during the resting state (100 nM vs. mM). This gradient is maintained by Ca2+-buffering proteins as well as by membrane-intrinsic Ca2+ transport systems capable of removing Ca2+ from the cytosol into the extracellular milieu. The Ca2+ extrusion is possible even uphill this very large concentration gradient.
To trigger cellular processes, myriads of cellular proteins, acting both locally and globally, have been adapted to bind Ca2+. Their affinities range from nanomolar to millimolar. In Ca2+ binding proteins, six to seven carboxyl and carbonyl groups are coordinated to surround Ca2+ in a pentagonal bipyramid (37). The helix-turn-helix motifs of the archetypical EF hand domain, the professional protein chelator of Ca2+, have negatively charged oxygen atoms to encompass Ca2+ within a 12 amino acid loop between two orthogonal α-helices. The affinities of EF hand domains for Ca2+ vary, depending on a variety of factors, ranging from critical amino acids in the Ca2+ binding loop to side chain packing in the protein core. The subsequent readout of Ca2+ signals employs downstream signaling proteins, which transmit the Ca2+ message to cellular effectors.
Cellular Factors That Determine Ca2+ Signaling in the Brain
Role of mitochondria and endoplasmic reticulum
In intracellular Ca2+ signaling, mitochondria accumulate Ca2+ from the cytosol. Mitochondrial Ca2+ accumulation is a tightly controlled process. It regulates three Ca2+-sensitive dehydrogenases of the citric acid cycle and thus controls the synthesis of ATP. Specifically, pyruvate dehydrogenase, isocitrate dehydrogenase, oxoglutarate dehydrogenase, the ATP synthase (complex V), and the adenine nucleotide translocase are activated by Ca2+. Further, Ca2+ from mitochondria shapes the amplitude and spatio-temporal patterns of [Ca2+]i signals, and is instrumental to determining cell death or survival. Mitochondria can store large amounts of Ca2+ in the matrix without dangerously increasing its osmotic concentration, since they accumulate inorganic phosphate alongside with Ca2+, and thus precipitate in the matrix deposits of amorphous hydroxyapatite. When mitochondria accumulate excessive Ca2+, however, they trigger a vicious cycle that will exacerbate the cellular Ca2+ overload. Further, mitochondria produce nitric oxide (NO), and in stress situations, mitochondria release apoptogenic factors into the cytosol. Moreover, mitochondrial dynamics (fission, fusion, and migration) is important for neurotransmission, synaptic maintenance, and neuronal survival.
Regulated Ca2+ release from the endoplasmic reticulum (ER) controls many neuronal functions, from plasmalemmal excitability to synaptic plasticity. Enzymatic cascades that are localized in the ER, dependent on the Ca2+ concentration in the ER lumen, integrate rapid Ca2+ signaling with long-lasting adaptive responses through modifications in protein synthesis and processing (14). Mitochondria form junctions with the ER that support signal transduction and biosynthetic pathways and affect distribution of the organelles. These junctions have a pivotal role in mediating Ca2+ signal propagation to the mitochondria. In the ER membrane, Ca2+ release channels and Ca2+ pumps provide for excitability (38).
In neurodegenerative diseases and aging, mitochondrial dysfunction is associated with compromised cellular energy production, the induction of apoptosis, and the generation of oxidative stress (33, 76).
Cross-talk between calcium and reactive oxygen species signaling
It is now well established that cross-talk between Ca2+ and redox signals plays a key role in physiological functions in the brain. However, conditions that promote oxidative/nitrosative stress result in excessive Ca2+ release that can provoke pathological responses and neuronal death (55, 101).
Reactive oxygen species (ROS) are generated by tightly regulated NADPH oxidases, which were found recently even in neurons (82, 93). Further, main sources of ROS are mitochondria, where free oxygen radicals are generated as by-products from the electron transport chain and from enzymes of the tricarbonic acid cycle (4, 25). Excessive stimulation of NADPH oxidases, disturbed electron transport chain, or tricarbonic acid cycle results in oxidative stress, a process that damages cell structures (5). This is particularly important in the nervous system, since this relatively small tissue accounts for over 20% of the oxygen consumption of the body and, as a result, produces large quantities of ROS. Additionally, the nervous system is particularly sensitive to oxidative stress because of enrichment of polyunsaturated fatty acids in many of the nerve cell membranes. Finally, oxygen radicals generated by xanthine oxidase are shown to play a significant role in neuronal cell death after ischemia (3).
Components of ROS homeostasis are regulated by Ca2+-dependent pathways. Thus, a positive correlation between the Ca2+-dependent mitochondrial metabolic rate and ROS generation was shown (107). Further, Ca2+ stimulates NO synthase, which has been shown to inhibit complex IV and in turn leads to ROS production at the complex III (41). Similarly, increased [Ca2+]i during reoxygenation after anoxia correlates with ROS generation from NADPH oxidase in neurons (3). Free radical generation in response to β-amyloid (Aβ) was shown to be dependent on extracellular Ca2+ and to be prevented by inhibition of NADPH oxidase (2).
Conversely, ROS modify Ca2+ signaling proteins and reshape local and global Ca2+ amplitudes and kinetics. Many of the Ca2+ transporters and signaling proteins in the ER-mitochondrial web are sensitive to redox regulation and are directly exposed to the ROS produced in the mitochondria and ER (38). ROS have been shown to modulate directly ryanodine receptors (RyR). Moreover, ROS induce oxidation of NO to nitrosium ions (NO+) and the subsequent reaction with free thiols in RyR to form S-nitrosothiol, which stimulates RyR-mediated Ca2+ release from the ER (48). Similarly, ROS has been shown to stimulate inositol(1,4,5)trisphosphate receptors (InsP3R). Further, sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA) and plasma membrane Ca2+ ATPases (PMCAs) were shown to be inhibited by ROS in the heart, pancreas, and brain, and Na+/Ca2+ exchangers (NCX) were shown to be stimulated or inhibited during oxidative stress (41).
Homo- and hetereocellular interactions in Ca2+ regulation of neural cells
The major cellular constituents of the central nervous system (CNS) are three cell types of neural descent, neurons, astrocytes, and oligodendrocytes, as well as one cell type of myeloid descent, namely, microglia. Whereas neurons comprise not more than 10% of the cells in the brain, astrocytes comprise approximately half of the volume of the adult mammalian brain. They represent the primary neuronal trophic element since they were shown to supplement neurons with nutrients, to modulate the extracellular milieu mainly by buffering the glutamate level and by eliminating ROS (52). Astrocytes, which are organized into distinct nonoverlapping domains, interact intimately with synapses and the cerebrovasculature (7). Astrocytes express a large variety of G protein-coupled receptors (GPCR) that affect a diverse set of signaling cascades, including many different GPCR coupled to Gq, which are activated by neurotransmitters released from presynaptic terminals to produce astrocytic increase of Ca2+ level. Prevailing evidence indicates that spontaneous astrocytic Ca2+ rise generally remains localized and is unlikely to activate distant astrocytes via intercellular Ca2+ waves (15).
Neuroactive substances, primarily glutamate and ATP, are secreted from astrocytes. They act back onto synapses in a process known as gliotransmission (7). Very recently, it has been reported that neither increasing nor obliterating astrocytic Ca2+ fluxes affects spontaneous and evoked excitatory synaptic transmission or synaptic plasticity (6). These findings suggest that the mechanism of gliotransmission in the three-partite synapse might be Ca2+ independent and thus needs to be reconsidered.
Ca2+ Toolkit in Neural Signaling and in Control of Neurodegenerative Processes
Ca2+ fluxes across the plasma membrane and between intracellular compartments play critical roles in fundamental functions of neurons. Ca2+ signals are produced in response to stimuli, like membrane depolarization, mechanical stretch, noxious insults, extracellular agonists, intracellular messengers, and the depletion of intracellular Ca2+ stores. Neurite outgrowth, synaptogenesis, synaptic transmission, plasticity, and cell survival in degeneration processes are regulated by Ca2+ signals.
The diversity of events controlled by Ca2+ is a consequence of distinct types of signals that differ spatially, temporally, and in magnitude. A given change of the Ca2+ concentration modifies functions in the same type of neurons in a multitude of ways and, thus, produces distinct outcomes over short, medium, or long distances and times.
The following sections summarize important components of the Ca2+ signaling system in neural cells that are able to create a diverse array of signaling units that can deliver Ca2+ signals with very different spatial and temporal properties (17). Figure 1 schematically depicts the Ca2+ regulating proteins, which are involved in normal neurophysiological processes, firstly, in the plasma membrane and, secondly, in intracellular organelles, ER, mitochondria, and the nucleus. These proteins, in a coordinate manner, induce [Ca2+]i changes, from where all Ca2+ signals emanate.
G protein-coupled receptors
Over 90% of nonsensory GPCR are expressed in the brain. In the CNS, GPCR function primarily, but not exclusively, as mediators of slow neuromodulators rather than of fast neurotransmitters, and their role is critical for normal brain function. After activation, GPCR can be desensitized by being phosphorylated by members of the family of GPCR kinases (44). Phosphorylated receptors are then bound by arrestins, which prevent further stimulation of G proteins and downstream signaling pathways. Under- or overactivity of many individual GPCR systems in the brain may contribute to pathological conditions, ranging from hypo-dopaminergic movement disorders to mania and depression. Thus, these receptors are primary or downstream targets for a variety of useful therapeutic agents. Decreased levels of extracellular Ca2+ are sensed by G protein-coupled Ca2+ sensing receptors that initiate the phospholipase C pathway. Expression of these receptors in glial cells indicates potential roles in the maintenance of local ionic homeostasis (21). In gonadotropin-releasing hormone neurons the activation of these Ca2+ receptors promotes cell migration (35).
Ion channels
Ion channels provide for an aqueous bridge across the hydrophobic environment of the plasmalemma allowing for selective transition of ions across these membranes. The channel proteins are constantly flickering between an activated state (open), a deactivated state (closed), and an inactivated state (closed)—often in a voltage- and time dependent fashion. For any condition, there exists an equilibrium, which can be shifted by binding of particular ions or molecules.
Voltage-gated Ca2+ channels
The family of voltage-gated Ca2+ channels (CaV) transduces cell surface membrane potential changes into local rise of [Ca2+]i. These ion channels play a role in the generation and propagation of the nerve impulse and in cell homeostasis. CaV are formed as a complex of several subunits, such as α1, α2δ, β1–4, and γ. The α1 subunit forms the ion-conducting pore, whereas the associated subunits have several auxiliary functions, including control of channel expression and modulation of current kinetics. The voltage sensor in the pore-containing subunit comprises a series of positively charged amino acid residues, which are physically displaced by the change in the membrane electric field: the physical displacement in turn causes a conformational change in the ion channel protein, leading to channel opening.
Molecular biology studies have identified 10 different genes in mammals, each coding for a different α1 subunit. According to sequence similarities, they are divided into three subfamilies, Cav1, Cav2, and Cav3. In the laboratory, it is possible to distinguish them by studying their physiological roles and/or inhibition by specific toxins. The Cav1 isoforms correspond to the dihydropyridine-sensitive L-type channels, which are responsible for excitation–contraction coupling of skeletal, smooth and cardiac muscle and for hormone secretion in endocrine cells. The Cav2 isoforms represent the neuronal currents (N-, R-, P/Q-), sensitive to spider and cone snail toxins. The N-type channel is blocked by ω-conotoxin, and the R-type channel (R stands for resistant to the other blockers and toxins) is involved in so far poorly defined processes in the brain. The closely related P/Q-type channel is blocked by ω-agatoxins. The Cav3 isoforms form the so-called T-type channels, which are insensitive to either the typical L-type blockers or the organic non-L-type inhibitors (32, 40). The modulation of voltage-gated ion channels by signaling pathways activated by GPCR constitutes widespread mechanisms for regulating neuronal excitability, neurotransmitter release, and neuronal plasticity.
Receptor-operated Ca2+ channels
Receptor-operated channels (ionotropic receptors) open in response to specific ligand molecules binding to the extracellular domain of the receptor. Ligand binding causes a conformational change in the structure of the channel protein that ultimately leads to the opening of the channel gate and subsequent ion flux across the plasma membrane. Examples of such channels include the monovalent cation-permeable nicotinic acetycholine receptor, ionotropic glutamate-gated receptors and ATP-gated P2X receptors, and the anion-permeable γ-aminobutyric acid-gated receptor.
Seven genes code for P2X receptor subunits, which are 40%–50% identical in amino acid sequence. All P2X receptors are permeable to small monovalent cations; some have significant Ca2+ permeability. Functional responses of P2X receptors are seen in neurons and glia cells. On sensory nerves, P2X receptors are involved in the initiation of afferent signals in several viscera (e.g., bladder, intestine) and play a key role in sensing tissue damage, pain, and inflammatory stimuli. Paracrine roles for ATP signaling through P2X receptors are likely in the neurohypophysis (78).
N-methyl-D-aspartate receptors (NMDAR) are a subtype of ionotropic glutamate receptors with an important role in the physiology and pathophysiology in the mammalian CNS. Physiological levels of NMDAR activity play important roles in neurotransmission and synaptic plasticity and can promote neuronal survival and resistance to trauma.
Inappropriate levels of Ca2+ influx through the NMDAR, however, can contribute to neuronal loss under pathophysiological conditions. This is called excitotoxicity. Increased understanding of the molecular mechanisms underlying both the neuroprotective and neurodestructive effects of NMDAR activation will lead to the discovery of new therapeutic targets and strategies for excitotoxic disorders (47, 80).
Mitochondrial channels
An electrophoretic uniporter mediates the charge-uncompensated entry of Ca2+ into mitochondria in response to the high negative membrane potential generated by the asymmetric topography and operation of the respiratory chain components (54). This Ca2+ uptake is mediated by the mitochondrial Ca2+ uniporter located in the organelle's inner membrane. The uniporter passes Ca2+ down the electrochemical gradient maintained across this membrane without direct coupling to ATP hydrolysis or transport of other ions.
Additionally, Ca2+-activated potassium channels (KCa; see the section Ca2+-sensitive potassium channels) were found also in mitochondrial inner membranes. They might function to stabilize the mitochondrial membrane and thereby have a neuroprotective function (57).
Transient receptor potential ion channel
The family of transient receptor potential (TRP) channels now comprises >30 members subdivided into seven families. TRP channels are widely expressed in the CNS where they contribute to changes in [Ca2+]i by providing Ca2+ entry pathways, by modulating the driving force for the Ca2+ entry, and very likely also by providing intracellular pathways for Ca2+ release from cellular organelles. TRP channels are activated by a wide range of stimuli, including intra- and extracellular messengers, chemical, mechanical, and osmotic stress, and some by the filling state of intracellular Ca2+ stores (77, 83).
Receptor-operated Ca2+ channels of the ER and acidic stores
RyR and InsP3R are localized in the ER and secondarily in the internal nuclear membrane (66) and predominantly operated by second messengers. Cyclic ADP ribose is synthesized from NAD+ by the bifunctional ectoenzymes of the CD38 family (49). InsP3 originates from hydrolysis from membrane bound phosphatidylinositol (4,5)P2, as induced by Gq-activated phospholipase Cβ (42). The depletion of Ca2+ from the ER is sensed by stromal interacting molecule (STIM) proteins. They oligomerize, translocate to junctions adjacent to the plasma membrane, organize Orai or TRP channel proteins into clusters, and open these channels to induce store-operated Ca2+ entry (27).
There are at least three different isoforms of RyR, but only RyR3 is expressed in the brain. Redox modification of RyR channels has physiological and pathological consequences for neuronal function (41, 48).
InsP3R constitute a family of three paralogs, from which InsP3R1 is expressed in neurons. InsP3R mediate cell physiological processes ranging from gene transcription to forming learning traces for memory (42). Synaptic activity regulates the level of expression of InsP3R1 in neurons (28). Metabotropic and ionotropic glutamate receptors collaborate to generate InsP3 signals (50). Phosphorylation dynamics of InsP3R1 modulate intracellular Ca2+ release (84). InsP3R were demonstrated to be activated furthermore by calmodulin-like neuronal Ca2+-binding proteins (53).
Store-operated Ca2+ entry has been shown to be regulated by both Ca2+-selective RyR or InsP3R and Ca2+-independent phospholipase A2 as described before (89, 91).
Ca2+ from intracellular acidic stores has been shown to be mobilized by nicotinic acid-adenine dinucleotide phosphate. Cellular levels change in response to a variety of agonists, confirming its role as a Ca2+-mobilizing messenger also in the nervous system (18). Nicotinic acid-adenine dinucleotide phosphate interacts with InsP3 and cyclic ADP-ribose in shaping cytosolic Ca2+ signals in the cytosol as well as in the nucleus (18).
Ca2+-sensitive potassium channels
KCa share the basic architecture with voltage-gated potassium channels. On the basis of the size of ionic conductance, being big, intermediate, or small, KCa are divided into three categories, called BK channels (KCa1.1), IK channels (KCa5.1), and SK channels (KCa2.1, KCa2.2, KCa2.3, KCa3.1, KCa4.1, and KCa4.2) (104). They are present in a wide range of excitable and nonexcitable cells and are tightly associated with calmodulin. On activation by low concentrations of Ca2+, KCa channel opening results in hyperpolarization of the membrane and changes in cellular excitability. Their activation limits the firing frequency of action potentials and is important for regulation of after-hyperpolarization in central neurons. KCa are involved in induction of synaptic plasticity and therefore play important roles in memory and learning (94).
Calcium binding proteins and transcriptional networks
Interaction of Ca2+ with specific sensors transduces the specificities of the [Ca2+]i signal in terms of amplitude, duration, frequency, and spatial distributions into changes in the transcription rate of specific genes and cellular functions (86). Further, Ca2+-mediated posttranslational modifications on appropriate molecules in the transcriptional machinery result in modified expression of specific single genes or in readjustments of the activity of entire transcriptional networks (70).
A number of Ca2+ binding proteins are expressed in the nervous system. Their affinity for Ca2+, their localization in relation to the Ca2+ signal, and their interactions with other proteins determine their specific role. Functionally, they may be distinguished into two groups. Being chelators, they can act as Ca2+ buffers, which modify the spatiotemporal aspects of Ca2+ transients. As Ca2+ sensors, these proteins have a higher affinity and lower capacity towards Ca2+ and translate [Ca2+]i changes into signaling cascades.
Three basic mechanisms that follow the recognition of changes in [Ca2+]i by a Ca2+ sensor were differentiated (69). First, there is an activation of signaling cascades of phosphorylation and dephosphorylation that either modify the transactivating properties of transcription factors or affect the nucleosome structure. This changes the accessibility of the RNA polymerase II to specific genes. In some occasions, phosphorylation and dephosphorylation are coupled events that act on a particular protein or even on a particular phosphorylated amino acid residue. In those cases, the specificities of the Ca2+ signal to activate the two events of phosphorylation and dephosphorylation alternatively require a delicate fine-tuning. Two major phosphatases in this context are calcineurin, also termed protein phosphatase 2B (PP2B), and PP1 (70). Second, there is an induction of Ca2+-dependent protein–protein interactions between the Ca2+ sensor and transcription factors. Because of this interaction, binding to DNA or recruitment of certain cofactors is modified. Third, Ca2+-induced changes in the binding properties of the calcium sensor to specific sites in the DNA can be found.
The best studied example among the Ca2+ sensors is the ubiquitously occurring calmodulin with four EF-hand binding motifs (69). Neuronal Ca2+ sensor-1 (NCS-1) is a member of five NCS proteins and interacts with different other proteins in a Ca2+-dependent or Ca2+-independent manner (26). Recently, it has been shown that NCS-1 has a role in learning and memory (87). Calretinin, calbindin D-28, and parvalbumin belong to a family of Ca2+-binding proteins, which in man comprises >200 members. They are particularly enriched in specific cerebellar neurons. Several studies suggest that these proteins have evolved as functionally distinct, physiologically relevant modulators of intracellular Ca2+ transients. They are involved in regulating the Ca2+ pools, which are critical for synaptic plasticity. Whether they play a major role as endogenous neuroprotectants is not clear.
The cAMP-dependent transcription factor CREB (cAMP response element binding) is thought in neurons to be involved in the formation of long-term memory and to mediate neuronal survival (29). Distinct protein kinase signaling pathways mediate converging effects of Ca2+ and cAMP on CREB activation. Binding of a neurotransmitter to its receptor may be coupled to activation of the cAMP-dependent protein kinase. Alternatively, elevation of [Ca2+]i leads to activation of a Ca2+/calmodulin-dependent kinase (CaMK) (90). CaMKs and the protein kinase C isoenzymes represent two major groups of Ca2+ sensitive enzymes. CaMKII represents between 1% and 2% of the protein in the brain. Besides transcription factor regulation, CaMKII plays a role in neurotransmitter secretion, glycogen metabolism, and synaptic plasticity (61).
Calcium pumps and exchangers
ATP-driven Ca2+ pumps and ion gradient-dependent Ca2+ exchangers are the major systems responsible for uphill transport of Ca2+ across membranes. Both types of transporters are simultaneously expressed in both astrocytes and neurons. This implies that the two transporters with different kinetic properties have different functions in these cells.
Ca2+/cation antiporter
Ca2+/cation antiporters are a superfamily containing three members, which subserve a variety of roles, including neuronal signaling (92). The NCX, a 9-transmembrane domain protein able to couple the efflux/influx of Ca2+ to the influx/efflux of Na+ ions, operates in a bidirectional way. It is the major regulator of Na+ and Ca2+ homeostasis. In the brain, unlike in other tissues, this exchanger is present as three different gene products, NCX1, NCX2, and NCX3, with a distinct distribution pattern in different brain regions. Under physiological conditions, its primary role is to extrude Ca2+ through a forward mode of operation. NCX responds to a depolarization or to an increase in intracellular Ca2+ concentration coupled to receptor stimulation.
The Na+/Ca2+–K+ exchanger (NCKX) transports K+ and Ca2+ in exchange for Na+, and comprises five members, four of which (NCKX2-5) are expressed in the brain. The NCKX proteins play a role in regulating Ca2+ flux in environments, which experience wide and frequent fluctuations in Na+ concentration. Evidence emerges for multiple roles for these exchangers, also in processes such as synaptic plasticity.
The Ca2+/cation exchanger branch has only one mammalian member, Na+/Ca2+–Li+ exchanger (NCKX6 or NCLX), whose physiological function remains unclear, despite a broad pattern of expression (63).
Mitochondrial exchangers
While in nonexcitable cells the Ca2+ efflux from mitochondria is essentially mediated by the H+/Ca2+ exchanger, in neurons and other excitable cells, the mitochondrial NCX (NCXmito) is the main system extruding Ca2+ ions from the mitochondrial matrix. NCXmito was shown to have an impact on mitochondrial physiology by controlling the activity of the Ca2+-sensitive enzymes pyruvate-, α-ketoglutarate-, and isocitrate-dehydrogenase, and by consuming energy because of its indirect effect on the H+ gradient (30). NCXmito determines a shoulder in neuronal [Ca2+]c responses to neurotransmitters and depolarizing stimuli. This shoulder may outlast the stimulus duration. The persistent NCXmito-dependent Ca2+ release has a role in post-tetanic potentiation, a form of short-term synaptic plasticity. Published data suggest that the three isoforms of plasma membrane NCX contribute to NCXmito in neurons and astrocytes (30).
Ca2+ shuttling between the ER and mitochondria was detected as the pacemaker of Ca2+ oscillations. Ca2+ release from the ER induces the initial Ca2+ oscillation and loads mitochondria with Ca2+. The following Ca2+ peak is induced by means of NCXmito. Increased [(Ca2+]i provokes further peaks by regenerative Ca2+ release from ER, which generates partial reloading of the mitochondria. This sequence is repeated until mitochondrial Ca2+ is depleted (51).
Plasma membrane Ca2+ ATPases
PMCAs are quickly activated by a rise in [Ca2+]i and affected by binding of Ca2+-calmodulin. In the brain, four separate genes code for the major PMCA isoforms 1–4. In particular, PMCA2 is enriched primarily in neurons in some CNS regions. The identification of a growing number of further specific interacting proteins with regulatory, targeting, and signaling functions supports the paradigm that PMCAs are not only responsible for global Ca2+ homeostasis but are highly dynamic participants in spatially defined Ca2+ signaling (22).
Endoplasmic reticulum Ca2+ATPase
The ER serves as a dynamic Ca2+ pool being thus involved in rapid signaling events in nerve cells associated with cell stimulation by either electrical (action potential) or chemical (neurotransmitters) signals. This function is supported by Ca2+ release channels (InsP3R and RyR) and SERCA Ca2+-ATPases residing in the endoplasmic membrane (102). In addition, the ER provides a specific environment for the posttranslational protein processing and transport of various molecules toward their final destination. In parallel, the ER acts as a calcium tunnel, which facilitates Ca2+ movements within the cell by avoiding cytoplasmic routes. Finally, the ER appears as a source of numerous signals aimed at the nucleus and involved in long-lasting adaptive cellular responses. All these important functions are controlled by intra-ER free Ca2+, which integrates various signaling events and establishes a link between fast signaling, associated with ER Ca2+ release/Ca2+ uptake, and long-lasting adaptive responses relying primarily on the regulation of protein synthesis (14, 22). Recently, SERCA has to been shown to be functionally coupled to the Ca2+ sensor in the ER, called STIM, and Orai, a member of the TRP family, to allow efficient refilling of the ER (65).
Disruption of ER Ca2+ homeostasis triggers several forms of cellular stress responses and is intimately involved in neurodegeneration and neuronal cell death (105).
Dysregulation of Ca2+ Signaling in Brain and Neural Degeneration
The central role of Ca2+ in signaling functions in brain underlines its potential relevance for neurodegenerative diseases, a heterogeneous group of disorders characterized by gradual and progressive, selective loss of anatomically or physiologically related neuronal systems. Despite the wide spectrum of appearances of these diseases, there are striking similarities in the molecular pathogenesis of these diseases as they all involve dysregulation of Ca2+ homeostasis and signaling. This is associated with alterations of Ca2+ buffering capacities, deregulation of Ca2+ channel activities, and alterations of other Ca2+-regulating proteins due to excitotoxicity, perturbed energy metabolism, and oxidative stress. Abnormal cellular Ca2+ load can trigger cell death by activating proteases, by reinforcing signals leading to caspase activation or by triggering other catabolic processes mediated by lipases and nucleases.
Involvement of ER and mitochondria in Ca2+ homeostasis is an important common theme in neurodegenerative diseases, since these organelles are intimately involved in neuronal cell death (102). The link between Ca2+ dysregulation, mitochondria, and cellular derangement became particularly evident, when usage of animals as genetic disease models and analysis of the impact of environmental factors allowed to identify common traits in the pathogenic routes for these diseases (33, 60).
Neurological diseases should be also considered as gliopathologies, which determine the progression and final outcome of the neuropathological process (75). Glial function is closely regulated by cellular Ca2+ signaling that underlies the so-called glial calcium excitability. Glial Ca2+ signals triggered by activation of multiple GPCR are primarily driven by Ca2+ release from the ER (52).
The identification of precise neurotoxic molecular events in neurodegenerative disorders is a challenging task. A recent collection of overviews covered the role of imbalanced Ca2+ homeostasis and pathological Ca2+ signaling in various neurological diseases (74). We will focus in the following section on the question of how perturbation of Ca2+ homeostasis contributes to the pathophysiology of specified neurodegenerative disorders (12, 36, 60, 67).
Aging
Oxidative and metabolic stress, and impaired cellular stress adaptation are mechanisms of aging that render neurons vulnerable to degeneration. Many Ca2+-dependent processes, such as susceptibility to neurotoxicity, the after-hyperpolarization amplitude, induction of synaptic plasticity, long-term potentiation, long-term depression, and cell excitability are altered with age (43). Indeed, multiple lines of evidence have implicated Ca2+ dysregulation in brain aging and dementia. These changes have been associated with age-related deficits in learning and memory.
Aging-related increases in the Ca2+ spikes and currents result from changes in local Ca2+ levels. There is evidence for an increased L-type Ca2+ channel activity functionally linked to RyR. In turn, the increased Ca2+ transients result in dysregulation of multiple Ca2+-dependent processes and, through different pathways, in accelerated functional decline during aging (43, 99).
Alzheimer's disease
Alzheimer's disease (AD) is the most common age-related dementia in which patients show neurodegeneration and loss of cognitive abilities. Cognitive impairment and emotional disturbances in AD result from the degeneration of synapses and neuronal death in the limbic system and some regions of the cerebral cortex. Biochemically, AD is characterized by the perturbed expression and subsequent accumulation of several proteins, such as reelin and presenilins (PS). Reelin is involved in regulation of neuronal migration, synaptic plasticity, and dendritic spine development. Presenilins are part of the γ-secretase protease complex and play a role in presynaptic neurotransmitter release, induction of long-term potentiation and in the modulation of [Ca2+]i. γ-Secretase in coordination with β-secretase induces overproduction of Aβ, which forms oligomers. Amyloid plaques and neurofibrillary tangles are found as protein aggregates in the brain cells in AD.
The Aβ hypothesis postulates that Aβ deposits are the fundamental cause of the disease. Figure 2 summarizes the Aβ-associated Ca2+ dysregulation combined with the Ca2+-dependent cell death pathways that are prominent in AD cellular pathology. Under normal conditions, a sequential cleavage of the Aβ precursor protein (APP) by β-secretase and γ-secretase generates Aβ. AD-causing mutations in APP and PS compromise normal processing of these proteins in the plasma membrane.
Central to the neurodegenerative process is the inability of neurons to properly regulate intracellular Ca2+ levels (67, 99). Thus, toxic forms of Aβ may induce Ca2+ influx into neurons by formation of an oligomeric pore in the plasma membrane, thereby rendering neurons vulnerable to excitotoxicity and apoptosis (19). Aβ interacts with Fe2+ and Cu+ to generate hydrogen peroxide and hydroxyl radical (HO•), resulting in membrane lipid peroxidation, which generates aldehydes that impair the function of PMCA. As a result, the membrane becomes depolarized. NMDAR channels and CaV open, and a flux of toxic amounts of Ca2+ into the cytoplasm follows (16).
In addition, Aβ accumulates in mitochondria and thereby impairs the activity of complexes III and IV of the respiratory chain (9). Further, evidence for an involvement of NCXmito in pathological mechanisms of AD was reported (30, 100). Aβ affects mitochondria, whereby it causes elevated cytoplasmic Ca2+ levels and oxidative stress, and it reduces ATP synthesis and further increases the Ca2+ overload and oxidative stress (60).
There is also evidence that PS modulate SERCA to alter Ca2+ uptake and release in the ER (19). This effect of PS results in excessive accumulation of Ca2+ in the ER and, as a consequence, enhances Ca2+ release through RyR, whose expression levels are increased in mutant PS1-expressing AD mouse models (96). In the cortex of AD patients, reelin levels were significantly increased compared with control brain. Interaction of reelin with the apolipoprotein E receptor 2 was shown to enhance Ca2+ influx through NMDAR channels by a mechanism involving a src family tyrosine kinsase. Amyloidogenic APP processing prevents the α-secretase from α-cleavage of APP, which would otherwise generate a secreted form of APP. The latter is normally produced in response to synaptic activity and is known to be involved in neuroprotective pathways. During AD, amyloidogenic processing also generates by proteolysis a free intracellular APP domain, designated amyloid intracellular C-terminal domain, which translocates to the nucleus and perturbs gene transcription that regulates Ca2+ homeostasis (19). Finally, Ca2+ homeostasis disruption mediated by TRP channels has been suggested in AD (106). High [Ca2+]i induces stimulation of neuronal NO synthase, which leads to production of reactive oxygen and nitrogen species and to the feedforward activation of TRPM7 and TRPM2-like currents.
Ischemia and brain energy deprivation
A few minutes after uncompensated brain ischemia, cell death pathways overcome survival-promoting pathways, leading to neuronal death through three interacting mechanisms: excitotoxicity attributable to excess glutamate, oxidative stress, and/or stimulation of apoptotic-like pathways (12, 62). Figure 3 highlights the mechanisms connected to Ca2+ dysregulation in ischemia/stroke-induced cell death. These mechanisms were shown above in Figure 1 within the context of normal physiology.
Glutamate activates NMDAR at synaptic and extra-synaptic sites, causing prolonged neuronal depolarization and triggering deregulation of cellular ion homeostasis, mainly [Ca2+]i and [Na+]i. The entry of Ca2+ through NMDAR is accepted as the major pathway leading to the excitotoxic, delayed cell death associated with the ischemic periods of stroke. As a consequence of the excitotoxic stimulus in neurons, calpains cleave NCX and PMCA (Fig. 3) and thus inhibit its capability to remove accumulated Ca2+ (13). On the other hand, during hypoxic conditions, a nuclear factor-κB-dependent increase of NCX1 activity was shown enabling Na+ extrusion and Ca2+ influx. This may help to refill the ER Ca2+ stores and to prevent ER stress during anoxic conditions, thus contributing to cell rescue (92).
The decrease in [Ca2+] in the extracellular space, resulting from NMDAR stimulation, disinhibits Ca2+-sensing channel currents, leading to a further decrease in extracellular [Ca2+] and also membrane depolarization, which enhances removal of the Mg2+ block from NMDAR. Similarly, the decrease in extracellular [Ca2+] disinhibits some ion channels, thus resulting in a more pronounced depolarization and further relief of the block of NMDAR (64).
During ischemia, mitochondria release Ca2+ via NCXmito inducing a depletion of ATP due to the decrease in mitochondrial membrane potential (ΔΨm) (73). In this condition, the operation of the NCXmito is shifted to the Ca2+ accumulation mode. It has been shown that NCXmito can go into its reverse mode of operation and then acts as an influx pathway for Ca2+ into the mitochondrial matrix (Fig. 3). Excessive rise of intramitochondrial Ca2+ is a trigger for mitochondrial permeability transition pore (mPTP) opening and apoptosis (30). The opening of the mPTP is a critical step in neurodegenerative processes (11, 45). This pore structure with its control elements provides a very promising target for neuroprotective strategies (45). Nevertheless, the biochemical composition of this pore is still a mystery despite many years of intense investigations.
Ischemia-induced local production of ROS increases high activity response of RyR2 by S-glutathionylation and thus amplifies the increase of [Ca2+]i (8, 24).
Members of the melastatin subfamily of TRP proteins, particularly TRPM7 and TRPM2, may play key roles in neuronal death that is activated by oxidative stress downstream from excitotoxic signaling pathways (1, 64). Moreover, spreading depression-like hypoxic depolarization after vascular stroke is associated with an increase in [Ca2+]i. Intriguingly, TRPM4 and 5 could be candidates for triggering this dramatic event, although at present there is no direct experimental evidence in support of this conjecture (10).
Parkinson's disease
Parkinson's disease (PD), the most frequent movement disorder, is caused by the progressive loss of the dopamine neurons within the substantia nigra pars compacta (SNc) and the associated deficiency of the neurotransmitter dopamine in the striatum. Most cases of PD occur sporadically with unknown cause, but mutations in several genes, such as α-synuclein, Parkin, DJ-1, PINK1, and LRRK2, have been linked to genetic forms of PD.
In humans and animal models, mitochondrial dysfunction is a defect occurring early in the pathogenesis of both sporadic and familial PD. Both PINK1 and Parkin play crucial roles in the regulation of mitochondrial dynamics and function. Mutations in DJ-1 and Parkin render animals more susceptible to oxidative stress, and mitochondrial toxins were implicated in sporadic PD. Mitochondrial association of α-synuclein in cells was also linked to impairment of respiratory complex I activity, oxidative modification of mitochondrial proteins, and increased levels of Ca2+ and NO (81). In autoptic samples of substantia nigra from patients affected with the disease the activity of complex I was shown to be reduced (23, 30).
L-type Ca2+ channels are engaged during autonomous pacemaking rendering SNc dopaminergic neurons susceptible to mitochondrial toxins. This indicates that homeostatic Ca2+ stress could determine their selective vulnerability (34, 97). Further, reduction in the cell surface expression of the TRP channel isoform 1 may be involved in dopaminergic neurodegeneration, and TRP channel isoform 1 may provide neuroprotection against PD-inducing agents (20).
Multiple sclerosis and brain inflammatory processes
Multiple sclerosis is characterized by inflammation, demyelination, oligodendrocyte death, gliosis, axonal damage, and neurodegeneration. The clinical symptoms include paresthesia, optic neuritis, diplopia, fatigue, paralysis, and cognitive dysfunction. NCX, PMCA2, several ion channels, and SERCA play critical roles in this type of neuronal pathology. Increase of Na+ concentration induces a reversal in the activity of NCX and the subsequent increase of [Ca2+]i. Reduction in PMCA2 expression causes injury due to activation of Ca2+-dependent proteases, including calpains and PPs. One consequence is the dephosphorylation of cytoskeletal proteins, such as neurofilaments. This affects neuronal stability and increases the vulnerability of cytoskeletal proteins (58, 71).
Huntington's disease
Huntington's disease (HD) is characterized by motor, cognitive, and psychiatric symptoms, including depression, personality changes, weight loss, and movement irregularity (chorea) developing in the terminal stage into severe akinesia (33). The disease is inherited in an autosomal dominant fashion. The mutant huntingtin gene was identified to be reponsible for the disease. This protein is considered to play a role in axonal transport, regulation of transcription, exocytosis, bioenergetic metabolism, prevention of apoptosis, and Ca2+ homeostasis (31).
Mitochondrial Ca2+ overload is a decisive commitment step for the disease. Thus, a facilitated opening of the mPTP in permeabilized mutant huntingtin-expressing cells was demonstrated (59). Mutant but not wild-type huntingtin directly impairs the mitochondrial function (98). Further, huntingtin forms a ternary complex with huntingtin-associated protein-1A and InsP3R1. In this complex, mutant huntingtin facilitates Ca2+ release from the ER and renders neurons more sensitive to Ca2+-mediated cellular dysfunction (98).
Epilepsy
Up to 50% of all cases of epilepsy are initiated by neurological insults. Status epilepticus, stroke, and traumatic brain injury are three major causes that can lead to the development of acquired epilepsy. The neurons that survive the increase in extracellular glutamate concentration and the perturbed Ca2+ homeostasis sustain long-term changes in Ca2+ signaling that are prominent features of the epileptic phenotype (39, 73).
Genes of Ca2+-dependent ion channels and several other genes contribute to the genetic background of the pathogenesis of idiopathic epilepsy syndromes (72). Idiopathic generalized epilepsies are inherited with additive effects of genetic variation. CaV are involved in the release of neurotransmitters and in the sustained depolarization phase of paroxysomal depolarisation shifts; they are also the genetic substrate of generalized tonic-clonic convulsions. Various Ca2+-regulated enzymes found in spines have been implicated in epileptogenesis, including the nonreceptor protein tyrosine kinases Src and Fyn, CaMKII, and calcineurin (68).
A broad variety of mutations in mitochondrial DNA or nuclear genes have been associated with epileptic phenotypes. Ca2+ entrance into mitochondria through the uniporter induces mitochondrial depolarization. Impairment of the mitochondrial respiratory chain causes an increased metabolic demand in epileptic neurons (30). Mitochondrial dysfunction has been identified as a cause of epileptic seizures. The cross-talk between astrocytes and neurons promotes increased dendritic Ca2+ levels and synchronous firing of neurons, a hallmark of epileptiform activity (56).
Refsum disease and accumulation of branched-chain phytanic acid
In a inherited peroxisomal disorder, Refsum disease, mutations in the PHYH gene cause a buildup of the saturated branched-chain fatty acid phytanic acid in the plasma and tissues. Clinical features of this and other leukosdystrophies result from the malformation of myelin sheaths and comprise neurologic damage, cerebellar degeneration, and peripheral neuropathy. Phytanic acid and its peroxisomal α-oxidation product pristanic acid were recently shown to induce mitochondrial depolarization, Ca2+ deregulation, ROS production, and cell death in brain cells (85).
Conclusions
Outlook: search for novel targets of protection against neurodegeneration related to Ca2+ dysregulation
The mechanisms of neural diseases reported in the Dysregulation of Ca2+ Signaling in Brain and Neural Degeneration section involve a broad spectrum of Ca2+ dysregulation. This proves that stabilization of neuronal Ca2+ homeostasis may retard cell degeneration in acute and chronic neurodegenerative conditions. Causal mutations of genes coding for Ca2+-regulating proteins are genetic risk factors. These act together with environmental factors to determine whether a neurodegenerative disease process develops. If we were able to identify the mechanisms that determine whether the nervous system adapts positively and copes with the stress, or shows a disease phenotype during development, then the disease processes could be averted. For that purpose, drugs targeting the Ca2+ homeostasis might be helpful.
In line with this concept, it can be positively noted that drugs that suppress Ca2+ influx support neuronal survival in models of neurodegenerative disorders. Indeed, beneficial effects of the CaV1 (L-type Ca2+ channel) blocker nimodipine and the NMDAR channel blocker memantine have been shown in AD patients. On the other hand, clinical trials of NMDAR antagonists have failed to prevent ischemia-induced cell death since these antagonists may be protective only in the early phase of the insult, but not at later stages (67).
Recent exciting developments in therapeutics for neurodegenerative disorders have been the use of immunization. If antibodies were able to remove Aβ from the brain, immunization would be expected to prevent or reverse also the Aβ-induced neuronal Ca2+ dysregulation. For individuals at high risk for AD, prophylactic treatment may be prescribed, including anti-inflammatory drugs and immunization (19). Administration of the CaV blockers bepridil and nitrendipine significantly ameliorated experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Similar results were obtained by inhibition of receptor-operated and other Ca2+-regulating channels (71). For HD, promising results have been published using a specific animal model of HD (79). In mice expressing the full-length mutant huntingtin, histone deacetylase inhibitors were shown to ameliorate the deficits in mitochondrion-dependent Ca2+ handling. Thus, the inhibitors induced neuroprotection by improving the neuronal ability to cope with excitotoxic stimuli. For PD, no proven neuroprotective therapy with regulation of the Ca2+ balance has been described up to now. The search for such treatments is vigorously pursued (97). For neuroprotection against damage after status epilepticus, early NMDAR antagonism has been proposed to block the fatal Ca2+ accumulation in neurons (103).
Open questions and further perspectives
To stimulate further the development of promising therapeutic agents, which target neuronal Ca2+ signaling, several open questions have to be elucidated. These questions concern (i) the impact of risk factors of disease on neuronal Ca2+ homeostasis, both at the molecular and the cellular level, (ii) the identification of the subset of neurons affected in a particular type of neuronal degeneration, (iii) further elucidation of interactions of different neural cell types in brain Ca2+ homeostasis, (iv) the role played by mitochondria in pathogenesis, and (v) the potential help of antioxidants and cellular energy-promoting agents in the context of Ca2+ homeostasis.
Development of neuroprotective strategies comprises the sophisticated analysis of the pathways to control Ca2+ homeostasis and the understanding of the sequences of downstream events of Ca2+ signaling. Distinct Ca2+ signals may define whether protection is initiated or not. For example, the protease thrombin at low concentrations mediates hippocampal neuroprotection against ischemia via activation of protease-activated receptors, but thrombin causes neuronal degeneration at high concentrations (95). Further, the involvement of phospholipase A2 activation in the up- or downregulation of [Ca2+]i in astrocytes promises neuroprotection (88). The development of better-focused antiexcitotoxic strategies requires considerations of pro-survival NMDAR signaling. The selective targeting of pro-death pathways downstream of the NMDAR may represent an effective therapeutic strategy (47). Cell death in ischemia depends on the neuronal subtype, the severity, and duration of the episode, and the position of the neuron within the lesion (infarct core or penumbra). The use of NMDAR antagonists that are activated only in the pathological state is a promising strategy to consider this fact. This should minimize negative side effects (46).
Although in animal models of neurodegenerative disorders many Ca2+ targeting drugs have been demonstrated to protect neurons, only few have been successful in preclinical trials. To speed up the advancement of promising drugs to therapeutic intervention, rigorous scientific evidence for the suggested mechanism of action of the compound in question is needed; additionally, critical clinical evaluation of neuroprotectants in combination with other therapies is necessary. Further, growing attention has to be directed to the stimulation of neuroregeneration.
Abbreviations Used
- Aβ
β-amyloid
- AD
Alzheimer's disease
- AICD
amyloid intracellular C-terminal domain
- APP
Aβ precursor protein
- Ca2+
calcium cations
- [Ca2+]i
intracellular free Ca2+ concentration
- CaMK
Ca2+/calmodulin-dependent kinase
- CaV
voltage-gated Ca2+ channels
- CNS
central nervous system
- CREB
cAMP response element binding
- ER
endoplasmic reticulum
- GPCR
G protein-coupled receptor
- HD
Huntington's disease
- InsP3R
- KCa
Ca2+-activated potassium channels
- MCU
mitochondrial Ca2+ uniporter
- mPTP
mitochondrial permeability transition pore
- NCKX
Na+/Ca2+–K+ exchanger
- NCS
neuronal Ca2+ sensor
- NCX
Na+/Ca2+ exchanger
- NCXmito
mitochondrial NCX
- NMDAR
N-methyl-D-aspartate receptor
- nNOS
neuronal NO synthase
- NO
nitric oxide
- PD
Parkinson's disease
- PS
presenilins
- PMCA
plasma membrane Ca2+ ATPases
- PP
protein phosphatase
- ROC
receptor-operated channels
- ROS
reactive oxygen species
- RyR
ryanodine receptor
- SERCA
sarco(endo)plasmic reticulum Ca2+-ATPases
- SNc
substantia nigra pars compacta
- STIM
stromal interacting molecule
- TRP
transient receptor potential
Acknowledgments
The work was supported by grants from Bundesministerium für Bildung und Forschung (BMBF), Europäischer Fonds für Regionalentwicklung (EFRE), and from Land Sachsen-Anhalt.
We apologize to many authors who have published substantial scientific contributions in the field of this specific calcium research whose work could not or not sufficiently be cited here. This is due to space restrictions.
References
- 1.Aarts MM. Tymianski M. TRPM7 and ischemic CNS injury. Neuroscientist. 2005;11:116–123. doi: 10.1177/1073858404272966. [DOI] [PubMed] [Google Scholar]
- 2.Abramov AY. Canevari L. Duchen MR. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta. 2004;1742:81–87. doi: 10.1016/j.bbamcr.2004.09.006. [DOI] [PubMed] [Google Scholar]
- 3.Abramov AY. Scorziello A. Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci. 2007;27:1129–1138. doi: 10.1523/JNEUROSCI.4468-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal. 2005;7:1140–1149. doi: 10.1089/ars.2005.7.1140. [DOI] [PubMed] [Google Scholar]
- 5.Addabbo F. Montagnani M. Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension. 2009;53:885–892. doi: 10.1161/HYPERTENSIONAHA.109.130054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Agulhon C. Fiacco TA. McCarthy KD. Hippocampal short- and long-term plasticity are not modulated by astrocyte Ca2+ signaling. Science. 2010;327:1250–1254. doi: 10.1126/science.1184821. [DOI] [PubMed] [Google Scholar]
- 7.Agulhon C. Petravicz J. McMullen AB. Sweger EJ. Minton SK. Taves SR. Casper KB. Fiacco TA. McCarthy KD. What is the role of astrocyte calcium in neurophysiology? Neuron. 2008;59:932–946. doi: 10.1016/j.neuron.2008.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Aley PK. Murray HJ. Boyle JP. Pearson HA. Peers C. Hypoxia stimulates Ca2+ release from intracellular stores in astrocytes via cyclic ADP ribose-mediated activation of ryanodine receptors. Cell Calcium. 2006;39:95–100. doi: 10.1016/j.ceca.2005.09.009. [DOI] [PubMed] [Google Scholar]
- 9.Anandatheerthavarada HK. Devi L. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist. 2007;13:626–638. doi: 10.1177/1073858407303536. [DOI] [PubMed] [Google Scholar]
- 10.Anderson TR. Andrew RD. Spreading depression: imaging and blockade in the rat neocortical brain slice. J Neurophysiol. 2002;88:2713–2725. doi: 10.1152/jn.00321.2002. [DOI] [PubMed] [Google Scholar]
- 11.Azarashvili T. Stricker R. Reiser G. The mitochondria permeability transition pore complex in brain with interacting proteins—promising targets for protection in neurodegenerative diseases. Biol Chem. 2010;391:619–629. doi: 10.1515/BC.2010.070. [DOI] [PubMed] [Google Scholar]
- 12.Bano D. Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. 2007;38:674–676. doi: 10.1161/01.STR.0000256294.46009.29. [DOI] [PubMed] [Google Scholar]
- 13.Bano D. Young KW. Guerin CJ. Lefeuvre R. Rothwell NJ. Naldini L. Rizzuto R. Carafoli E. Nicotera P. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell. 2005;120:275–285. doi: 10.1016/j.cell.2004.11.049. [DOI] [PubMed] [Google Scholar]
- 14.Bardo S. Cavazzini MG. Emptage N. The role of the endoplasmic reticulum Ca2+ store in the plasticity of central neurons. Trends Pharmacol Sci. 2006;27:78–84. doi: 10.1016/j.tips.2005.12.008. [DOI] [PubMed] [Google Scholar]
- 15.Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008;60:430–440. doi: 10.1016/j.neuron.2008.10.013. [DOI] [PubMed] [Google Scholar]
- 16.Berridge MJ. Calcium hypothesis of Alzheimer's disease. Pflugers Arch. 2010;459:441–449. doi: 10.1007/s00424-009-0736-1. [DOI] [PubMed] [Google Scholar]
- 17.Berridge MJ. Bootman MD. Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517–529. doi: 10.1038/nrm1155. [DOI] [PubMed] [Google Scholar]
- 18.Bezin S. Charpentier G. Fossier P. Cancela JM. The Ca2+-releasing messenger NAADP, a new player in the nervous system. J Physiol Paris. 2006;99:111–118. doi: 10.1016/j.jphysparis.2005.12.007. [DOI] [PubMed] [Google Scholar]
- 19.Bezprozvanny I. Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 2008;31:454–463. doi: 10.1016/j.tins.2008.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bollimuntha S. Singh BB. Shavali S. Sharma SK. Ebadi M. TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J Biol Chem. 2005;280:2132–2140. doi: 10.1074/jbc.M407384200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Breitwieser GE. Extracellular calcium as an integrator of tissue function. Int J Biochem Cell Biol. 2008;40:1467–1480. doi: 10.1016/j.biocel.2008.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Brini M. Carafoli E. Calcium pumps in health and disease. Physiol Rev. 2009;89:1341–1378. doi: 10.1152/physrev.00032.2008. [DOI] [PubMed] [Google Scholar]
- 23.Bueler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol. 2009;218:235–246. doi: 10.1016/j.expneurol.2009.03.006. [DOI] [PubMed] [Google Scholar]
- 24.Bull R. Finkelstein JP. Galvez J. Sanchez G. Donoso P. Behrens MI. Hidalgo C. Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex. J Neurosci. 2008;28:9463–9472. doi: 10.1523/JNEUROSCI.2286-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bunik VI. 2-Oxo acid dehydrogenase complexes in redox regulation. Eur J Biochem. 2003;270:1036–1042. doi: 10.1046/j.1432-1033.2003.03470.x. [DOI] [PubMed] [Google Scholar]
- 26.Burgoyne RD. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007;8:182–193. doi: 10.1038/nrn2093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cahalan MD. STIMulating store-operated Ca2+ entry. Nat Cell Biol. 2009;11:669–677. doi: 10.1038/ncb0609-669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cai W. Hisatsune C. Nakamura K. Nakamura T. Inoue T. Mikoshiba K. Activity-dependent expression of inositol 1,4,5-trisphosphate receptor type 1 in hippocampal neurons. J Biol Chem. 2004;279:23691–23698. doi: 10.1074/jbc.M313296200. [DOI] [PubMed] [Google Scholar]
- 29.Carlezon WA., Jr Duman RS. Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28:436–445. doi: 10.1016/j.tins.2005.06.005. [DOI] [PubMed] [Google Scholar]
- 30.Castaldo P. Cataldi M. Magi S. Lariccia V. Arcangeli S. Amoroso S. Role of the mitochondrial sodium/calcium exchanger in neuronal physiology and in the pathogenesis of neurological diseases. Prog Neurobiol. 2009;87:58–79. doi: 10.1016/j.pneurobio.2008.09.017. [DOI] [PubMed] [Google Scholar]
- 31.Cattaneo E. Zuccato C. Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci. 2005;6:919–930. doi: 10.1038/nrn1806. [DOI] [PubMed] [Google Scholar]
- 32.Catterall WA. Perez-Reyes E. Snutch TP. Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev. 2005;57:411–425. doi: 10.1124/pr.57.4.5. [DOI] [PubMed] [Google Scholar]
- 33.Celsi F. Pizzo P. Brini M. Leo S. Fotino C. Pinton P. Rizzuto R. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta. 2009;1787:335–344. doi: 10.1016/j.bbabio.2009.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chan CS. Gertler TS. Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci. 2009;32:249–256. doi: 10.1016/j.tins.2009.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chattopadhyay N. Jeong KH. Yano S. Huang S. Pang JL. Ren X. Terwilliger E. Kaiser UB. Vassilev PM. Pollak MR. Brown EM. Calcium receptor stimulates chemotaxis and secretion of MCP-1 in GnRH neurons in vitro: potential impact on reduced GnRH neuron population in CaR-null mice. Am J Physiol Endocrinol Metab. 2007;292:E523–E532. doi: 10.1152/ajpendo.00372.2005. [DOI] [PubMed] [Google Scholar]
- 36.Chinopoulos C. Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J. 2006;273:433–450. doi: 10.1111/j.1742-4658.2005.05103.x. [DOI] [PubMed] [Google Scholar]
- 37.Clapham DE. Calcium signaling. Cell. 2007;131:1047–1058. doi: 10.1016/j.cell.2007.11.028. [DOI] [PubMed] [Google Scholar]
- 38.Csordas G. Hajnóczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta. 2009;1787:1352–1362. doi: 10.1016/j.bbabio.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.De Lorenzo RJ. Sun DA. Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther. 2005;105:229–266. doi: 10.1016/j.pharmthera.2004.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dolphin AC. A short history of voltage-gated calcium channels. Br J Pharmacol. 2006;147(Suppl 1):S56–S62. doi: 10.1038/sj.bjp.0706442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Feissner RF. Skalska J. Gaum WE. Sheu SS. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci. 2009;14:1197–1218. doi: 10.2741/3303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Foskett JK. White C. Cheung KH. Mak DO. Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev. 2007;87:593–658. doi: 10.1152/physrev.00035.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Foster TC. Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell. 2007;6:319–325. doi: 10.1111/j.1474-9726.2007.00283.x. [DOI] [PubMed] [Google Scholar]
- 44.Gainetdinov RR. Premont RT. Bohn LM. Lefkowitz RJ. Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci. 2004;27:107–144. doi: 10.1146/annurev.neuro.27.070203.144206. [DOI] [PubMed] [Google Scholar]
- 45.Galluzzi L. Blomgren K. Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci. 2009;10:481–494. doi: 10.1038/nrn2665. [DOI] [PubMed] [Google Scholar]
- 46.Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology. 2008;55:363–389. doi: 10.1016/j.neuropharm.2007.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans. 2009;37:1147–1160. doi: 10.1042/BST0371147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hidalgo C. Cross talk between Ca2+ and redox signalling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels. Philos Trans R Soc Lond B Biol Sci. 2005;360:2237–2246. doi: 10.1098/rstb.2005.1759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Higashida H. Salmina AB. Olovyannikova RY. Hashii M. Yokoyama S. Koizumi K. Jin D. Liu HX. Lopatina O. Amina S. Islam MS. Huang JJ. Noda M. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem Int. 2007;51:192–199. doi: 10.1016/j.neuint.2007.06.023. [DOI] [PubMed] [Google Scholar]
- 50.Iino M. Ca2+-dependent inositol 1,4,5-trisphosphate and nitric oxide signaling in cerebellar neurons. J Pharmacol Sci. 2006;100:538–544. doi: 10.1254/jphs.cpj06006x. [DOI] [PubMed] [Google Scholar]
- 51.Iino M. Regulation of cell functions by Ca2+ oscillation. Adv Exp Med Biol. 2007;592:305–312. doi: 10.1007/978-4-431-38453-3_26. [DOI] [PubMed] [Google Scholar]
- 52.Kahlert S. Reiser G. Glial perspectives of metabolic states during cerebral hypoxia—calcium regulation and metabolic energy. Cell Calcium. 2004;36:295–302. doi: 10.1016/j.ceca.2004.02.009. [DOI] [PubMed] [Google Scholar]
- 53.Kasri NN. Holmes AM. Bultynck G. Parys JB. Bootman MD. Rietdorf K. Missiaen L. McDonald F. De Smedt H. Conway SJ. Holmes AB. Berridge MJ. Roderick HL. Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. EMBO J. 2004;23:312–321. doi: 10.1038/sj.emboj.7600037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kirichok Y. Krapivinsky G. Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427:360–364. doi: 10.1038/nature02246. [DOI] [PubMed] [Google Scholar]
- 55.Kishida KT. Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid Redox Signal. 2007;9:233–244. doi: 10.1089/ars.2007.9.ft-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kudin AP. Zsurka G. Elger CE. Kunz WS. Mitochondrial involvement in temporal lobe epilepsy. Exp Neurol. 2009;218:326–332. doi: 10.1016/j.expneurol.2009.02.014. [DOI] [PubMed] [Google Scholar]
- 57.Kulawiak B. Kudin AP. Szewczyk A. Kunz WS. BK channel openers inhibit ROS production of isolated rat brain mitochondria. Exp Neurol. 2008;212:543–547. doi: 10.1016/j.expneurol.2008.05.004. [DOI] [PubMed] [Google Scholar]
- 58.Kurnellas MP. Donahue KC. Elkabes S. Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers. Biochem Soc Trans. 2007;35:923–926. doi: 10.1042/BST0350923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Lim D. Fedrizzi L. Tartari M. Zuccato C. Cattaneo E. Brini M. Carafoli E. Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem. 2008;283:5780–5789. doi: 10.1074/jbc.M704704200. [DOI] [PubMed] [Google Scholar]
- 60.Lin MT. Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787–795. doi: 10.1038/nature05292. [DOI] [PubMed] [Google Scholar]
- 61.Lisman J. Schulman H. Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci. 2002;3:175–190. doi: 10.1038/nrn753. [DOI] [PubMed] [Google Scholar]
- 62.Lo EH. Moskowitz MA. Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke. 2005;36:189–192. doi: 10.1161/01.STR.0000153069.96296.fd. [DOI] [PubMed] [Google Scholar]
- 63.Lytton J. Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. Biochem J. 2007;406:365–382. doi: 10.1042/BJ20070619. [DOI] [PubMed] [Google Scholar]
- 64.MacDonald JF. Xiong ZG. Jackson MF. Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci. 2006;29:75–81. doi: 10.1016/j.tins.2005.12.001. [DOI] [PubMed] [Google Scholar]
- 65.Manjarres IM. Rodriguez-Garcia A. Alonso MT. Garcia-Sancho J. The sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) is the third element in capacitative calcium entry. Cell Calcium. 2010;47:412–418. doi: 10.1016/j.ceca.2010.03.001. [DOI] [PubMed] [Google Scholar]
- 66.Marchenko SM. Yarotskyy VV. Kovalenko TN. Kostyuk PG. Thomas RC. Spontaneously active and InsP3-activated ion channels in cell nuclei from rat cerebellar Purkinje and granule neurones. J Physiol. 2005;565:897–910. doi: 10.1113/jphysiol.2004.081299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Mattson MP. Calcium and neurodegeneration. Aging Cell. 2007;6:337–350. doi: 10.1111/j.1474-9726.2007.00275.x. [DOI] [PubMed] [Google Scholar]
- 68.McNamara JO. Huang YZ. Leonard AS. Molecular signaling mechanisms underlying epileptogenesis. Sci STKE. 2006;2006:re12. doi: 10.1126/stke.3562006re12. [DOI] [PubMed] [Google Scholar]
- 69.Mellström B. Naranjo JR. Mechanisms of Ca2+-dependent transcription. Curr Opin Neurobiol. 2001;11:312–319. doi: 10.1016/s0959-4388(00)00213-0. [DOI] [PubMed] [Google Scholar]
- 70.Mellström B. Savignac M. Gomez-Villafuertes R. Naranjo JR. Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev. 2008;88:421–449. doi: 10.1152/physrev.00041.2005. [DOI] [PubMed] [Google Scholar]
- 71.Meuth SG. Melzer N. Kleinschnitz C. Budde T. Wiendl H. [Multiple sclerosis—a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration] Nervenarzt. 2009;80:422–429. doi: 10.1007/s00115-008-2599-7. [DOI] [PubMed] [Google Scholar]
- 72.Mulley JC. Scheffer IE. Petrou S. Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol. 2003;16:171–176. doi: 10.1097/01.wco.0000063767.15877.c7. [DOI] [PubMed] [Google Scholar]
- 73.Nagarkatti N. Deshpande LS. DeLorenzo RJ. Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis. Expert Rev Neurother. 2009;9:813–824. doi: 10.1586/ern.09.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Nedergaard M. Verkhratsky A. Calcium dyshomeostasis and pathological calcium signalling in neurological diseases (editorial) Cell Calcium. 2010;47:101–102. doi: 10.1016/j.ceca.2009.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Nedergaard M. Rodriguez JJ. Verkhratsky A. Glial calcium and diseases of the nervous system. Cell Calcium. 2010;47:140–149. doi: 10.1016/j.ceca.2009.11.010. [DOI] [PubMed] [Google Scholar]
- 76.Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta. 2009;1787:1416–1424. doi: 10.1016/j.bbabio.2009.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Nilius B. Owsianik G. Voets T. Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165–217. doi: 10.1152/physrev.00021.2006. [DOI] [PubMed] [Google Scholar]
- 78.North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013–1067. doi: 10.1152/physrev.00015.2002. [DOI] [PubMed] [Google Scholar]
- 79.Oliveira JM. Chen S. Almeida S. Riley R. Goncalves J. Oliveira CR. Hayden MR. Nicholls DG. Ellerby LM. Rego AC. Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors. J Neurosci. 2006;26:11174–11186. doi: 10.1523/JNEUROSCI.3004-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Papadia S. Hardingham GE. The dichotomy of NMDA receptor signaling. Neuroscientist. 2007;13:572–579. doi: 10.1177/10738584070130060401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Parihar MS. Parihar A. Fujita M. Hashimoto M. Ghafourifar P. Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci. 2008;65:1272–1284. doi: 10.1007/s00018-008-7589-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Park KW. Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res. 2008;86:1053–1063. doi: 10.1002/jnr.21571. [DOI] [PubMed] [Google Scholar]
- 83.Pedersen SF. Owsianik G. Nilius B. TRP channels: an overview. Cell Calcium. 2005;38:233–252. doi: 10.1016/j.ceca.2005.06.028. [DOI] [PubMed] [Google Scholar]
- 84.Pieper AA. Brat DJ. O'Hearn E. Krug DK. Kaplin AI. Takahashi K. Greenberg JH. Ginty D. Molliver ME. Snyder SH. Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors. Neuroscience. 2001;102:433–444. doi: 10.1016/s0306-4522(00)00470-x. [DOI] [PubMed] [Google Scholar]
- 85.Rönicke S. Kruska N. Kahlert S. Reiser G. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes. Neurobiol Dis. 2009;36:401–410. doi: 10.1016/j.nbd.2009.08.005. [DOI] [PubMed] [Google Scholar]
- 86.Rössler OG. Thiel G. Thrombin induces Egr-1 expression in fibroblasts involving elevation of the intracellular Ca2+ concentration, phosphorylation of ERK and activation of ternary complex factor. BMC Mol Biol. 2009;10:40. doi: 10.1186/1471-2199-10-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Saab BJ. Georgiou J. Nath A. Lee FJ. Wang M. Michalon A. Liu F. Mansuy IM. Roder JC. NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron. 2009;63:643–656. doi: 10.1016/j.neuron.2009.08.014. [DOI] [PubMed] [Google Scholar]
- 88.Sergeeva M. Strokin M. Reiser G. Regulation of intracellular calcium levels by polyunsaturated fatty acids, arachidonic acid and docosahexaenoic acid, in astrocytes: possible involvement of phospholipase A2. Reprod Nutr Dev. 2005;45:633–646. doi: 10.1051/rnd:2005050. [DOI] [PubMed] [Google Scholar]
- 89.Sergeeva M. Strokin M. Wang H. Ubl JJ. Reiser G. Arachidonic acid in astrocytes blocks Ca2+ oscillations by inhibiting store-operated Ca2+ entry, and causes delayed Ca2+ influx. Cell Calcium. 2003;33:283–292. doi: 10.1016/s0143-4160(03)00011-3. [DOI] [PubMed] [Google Scholar]
- 90.Sheng M. McFadden G. Greenberg ME. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron. 1990;4:571–582. doi: 10.1016/0896-6273(90)90115-v. [DOI] [PubMed] [Google Scholar]
- 91.Singaravelu K. Lohr C. Deitmer JW. Calcium-independent phospholipase A2 mediates store-operated calcium entry in rat cerebellar granule cells. Cerebellum. 2008;7:467–481. doi: 10.1007/s12311-008-0050-z. [DOI] [PubMed] [Google Scholar]
- 92.Sirabella R. Secondo A. Pannaccione A. Scorziello A. Valsecchi V. Adornetto A. Bilo L. Di Renzo G. Annunziato L. Anoxia-induced NF-κB-dependent upregulation of NCX1 contributes to Ca2+ refilling into endoplasmic reticulum in cortical neurons. Stroke. 2009;40:922–929. doi: 10.1161/STROKEAHA.108.531962. [DOI] [PubMed] [Google Scholar]
- 93.Sorce S. Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal. 2009;11:2481–2504. doi: 10.1089/ars.2009.2578. [DOI] [PubMed] [Google Scholar]
- 94.Stocker M. Ca2+-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci. 2004;5:758–770. doi: 10.1038/nrn1516. [DOI] [PubMed] [Google Scholar]
- 95.Striggow F. Riek M. Breder J. Henrich-Noack P. Reymann KG. Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA. 2000;97:2264–2269. doi: 10.1073/pnas.040552897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Stutzmann GE. Smith I. Caccamo A. Oddo S. Parker I. Laferla F. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Ann NY Acad Sci. 2007;1097:265–277. doi: 10.1196/annals.1379.025. [DOI] [PubMed] [Google Scholar]
- 97.Surmeier DJ. Guzman JN. Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium. 2010;47:175–182. doi: 10.1016/j.ceca.2009.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Tang TS. Slow E. Lupu V. Stavrovskaya IG. Sugimori M. Llinas R. Kristal BS. Hayden MR. Bezprozvanny I. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci USA. 2005;102:2602–2607. doi: 10.1073/pnas.0409402102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Thibault O. Gant JC. Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell. 2007;6:307–317. doi: 10.1111/j.1474-9726.2007.00295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Thiffault C. Bennett JP., Jr Cyclical mitochondrial ΔΨM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca2+ exchange are reduced in Alzheimer's disease cybrids. Mitochondrion. 2005;5:109–119. doi: 10.1016/j.mito.2004.12.002. [DOI] [PubMed] [Google Scholar]
- 101.Valko M. Leibfritz D. Moncol J. Cronin MT. Mazur M. Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84. doi: 10.1016/j.biocel.2006.07.001. [DOI] [PubMed] [Google Scholar]
- 102.Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev. 2005;85:201–279. doi: 10.1152/physrev.00004.2004. [DOI] [PubMed] [Google Scholar]
- 103.Walker M. Neuroprotection in epilepsy. Epilepsia. 2007;48(Suppl 8):66–68. doi: 10.1111/j.1528-1167.2007.01354.x. [DOI] [PubMed] [Google Scholar]
- 104.Wei AD. Gutman GA. Aldrich R. Chandy KG. Grissmer S. Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev. 2005;57:463–472. doi: 10.1124/pr.57.4.9. [DOI] [PubMed] [Google Scholar]
- 105.Williams BL. Lipkin WI. Endoplasmic reticulum stress and neurodegeneration in rats neonatally infected with borna disease virus. J Virol. 2006;80:8613–8626. doi: 10.1128/JVI.00836-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Yamamoto S. Wajima T. Hara Y. Nishida M. Mori Y. Transient receptor potential channels in Alzheimer's disease. Biochim Biophys Acta. 2007;1772:958–967. doi: 10.1016/j.bbadis.2007.03.006. [DOI] [PubMed] [Google Scholar]
- 107.Zündorf G. Kahlert S. Bunik VI. Reiser G. α-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ. Neuroscience. 2009;158:610–616. doi: 10.1016/j.neuroscience.2008.10.015. [DOI] [PubMed] [Google Scholar]